The global cell expansion market is expected to reach USD 18.76 Billion by 2021 from USD 8.34 Billion in 2016 at a CAGR of 17.6%. The global market is broadly classified on the basis of product, cell type, application, end user, and region.

On the basis of product, the cell expansion market is segmented into consumables and instruments. The consumables segment is expected to account for the largest share of the global market in 2016. Consumables include reagents, media and serum, and disposables (tissue culture flasks, bioreactor accessories, and other disposables). The instruments segment comprises cell expansion supporting equipment, bioreactors, and automated cell expansion systems. Cell expansion supporting equipment includes flow cytometers, centrifuges, cell counters, and other supporting equipment. Bioreactors are further classified into microcarrier bioreactors and perfusion/hollow fiber reactors. The microcarrier bioreactors include microcarrier-based anchorage dependent and suspension-based anchorage independent bioreactors. The cell expansion supporting equipment segment is expected to account for largest share of the instruments market in 2016, owing to new product launches by market players.

On the basis of cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment is expected to account for the largest share of this market, owing to rising investments by governments and companies for cell-based research. Human cells include stem cells and differentiated cells. The stem cells segment is classified into adult stem cells, embryonic stem cells and induced pluripotent stem cells.

The application segments included in the market are regenerative medicine and stem cell research, cancer and cell-based research, and others. The regenerative medicine and stem cell research segment is expected to account for the largest share of the global market in 2016. Rising investments by companies for developing new and innovative products are driving the growth of this segment.

End users included in the cell expansion market are research institutes, biopharmaceutical and biotechnology companies, cell banks, and others. The research institutes segment is expected to account for the largest share of the global market in 2016. Rise in funding and grants by government organizations such as the National Institutes of Health (NIH) for stem cells and other cell-based research have resulted in the increasing use of cell expansion products in research institutes.

Geographically, the cell expansion market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by the increasing incidence of chronic diseases such as diabetes and cancer in North American countries.

The major players in the cell expansion market are Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).